CRP and COVID-19: A recent prospective cohort study of 102 hospitalised and 26 non-hospitalised COVID-19 patients showed that increased complement activation was characteristic for hospitalised patients, and that complement activation was significantly associated with markers of inflammation, such as CRP and IL-6 (35).